Expression of collagen XVII and ubiquitin-binding protein p62 in motor neuron disease

Brain Research

Volumn 1247, Issue , 2009, Pages 171-177

  Seppänen, Allan ^a,e   Pikkarainen, Maria ^a   Hartikainen, Päivi ^b   Hofmann, Silke C ^c   Majamaa, Kari ^d,e   Alafuzoff, Irina ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Collagen XVII; Motor neuron disease; p62

Indexed keywords

AMYLOID BETA PROTEIN; BINDING PROTEIN; COLLAGEN TYPE 17; POLYCLONAL ANTIBODY; PROTEIN P62; SEQUESTOSOME 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; GRANULAR CELL; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOGLOSSAL NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MENTAL DISEASE; MOTOR CORTEX; MOTOR NEURON DISEASE; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; SYMPTOMATOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; AUTOANTIGENS; BIOLOGICAL MARKERS; BRAIN; CEREBELLUM; COMORBIDITY; CYTOSKELETON; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEURONS; NON-FIBRILLAR COLLAGENS;

EID: 57349166535     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.10.020     Document Type: Article

References (25)

1. Alafuzoff, I., Arzberger, T., Al-Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del-Tredici, K., Ferrer, I., Gelpi, E., Giaccone, G., Graeber, M.B., Ince, P., Kamphorst, W., King, A., Korkolopoulou, P., Kovács, G.G., Larionov, S., Meyronet, D., Monoranu, C., Parchi, P., Patsouris, E., Roggendorf, W., Seilhean, D., Tagliavini, F., Stadelmann, C., Streichenberger, N., Thal, D.R., Wharton, S.B., Kretzschmar, H., in press. Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe Consortium. Brain Pathol.
2. Arai T., Nonaka T., Hasegawa M., Akiyama H., Yoshida M., Hashizume Y., Tsuchiya K., Oda T., and Ikeda K. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci. Lett. 15 (2003) 41-44
3. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., and Del-Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112 (2006) 389-404
4. Charcot, J.M., 1880. Lecon sur le maladies du systeme nerveux faites a ala Salpetriere. Paris, France, Vol II.
5. Chosidow O., Doppler V., Bensimon G., Joly P., Salachas F., Lacomblez L., Prost C., Camu W., Frances C., Herson S., and Meininger V. Bullous pemphigoid and amyotrophic lateral sclerosis a new clue for understanding the bullous disease?. Arch. Dermatol. 136 (2000) 521-524
6. Dickson D.W., Josephs K.A., and Amador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 114 (2007) 71-79
7. Franzke C.W., Bruckner P., and Bruckner-Tuderman L. Collagenous transmembrane proteins: recent insights into biology and pathology. J. Biol. Chem. 280 (2005) 4005-4008
8. Furukawa Y., Iseki E., Hino H., Odawara T., Ikeda K., Tsuchiya K., and Kosaka K. Ubiquitin and ubiquitin-related proteins in the brains of patients with atypical Pick's disease without Pick bodies and dementia with motor neuron disease. Neuropathology 24 (2004) 306-314
9. Geser F., Brandmeir N.J., Kwong L.K., Martinez-Lage M., Elman L., McCluskey L., Xie S.X., Lee V.M.-Y., and Trojanowski J.Q. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 65 (2008) 636-641
10. Hiji M., Takahashi T., Fukuba H., Yamashita H., Kohriyama T., and Matsumoto M. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathol. 116 (2008) 183-191
11. Kolde G., Bachus R., and Ludolph A.C. Skin involvement in amyotrophic lateral sclerosis. Lancet 4 (1996) 1226-1227
12. Kuusisto E., Kauppinen T., and Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol. 34 (2008) 169-180
13. Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., and Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 249 (2006) 13-18
14. Ono S., and Yamauchi M. Amyotrophic lateral sclerosis: increased solubility of skin collagen. Neurology 42 (1992) 1535-1539
15. Ono S., Toyokura Y., Mannen T., and Ishibashi Y. Amyotrophic lateral sclerosis: histologic, histochemical, and ultrastructural abnormalities of skin. Neurology 36 (1986) 948-956
16. Ono S., Mechanic G.L., and Yamauchi M. Amyotrophic lateral sclerosis: unusually low content of collagen in skin. J. Neurol. Sci. 100 (1990) 234-237
17. Ono S., Imai T., Munakata S., Takahashi K., Kanda F., Hashimoto K., Yamano T., Shimizu N., Nagao K., and Yamauchi M. Collagen abnormalities in the spinal cord from patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 160 (1998) 140-147
18. Parkinson N., Ince P.G., Smith M.O., Highley R., Skibinski G., Andersen P.M., Morrison K.E., Pall H.S., Hardiman O., Collinge J., Shaw P.J., and Fisher E.M. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67 (2006) 1074-1077
19. Pikkarainen M., Hartikainen P., and Alafuzoff I. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J. Neuropathol. Exp. Neurol. 67 (2008) 280-298
20. Provinciali L., Cangiotti A., Tulli D., Carboni V., and Cinti S. Skin abnormalities and autonomic involvement in the early stage of amyotrophic lateral sclerosis. J. Neurol. Sci. 126 (1994) 54-61
21. Schmidt E., Wehr B., Wolf K., Sitaru C., Bröcker E.B., and Zillikens D. Localisation of bullous pemphigoid antigen 180 (BP180) in cultured human keratinocytes: functionally relevant modification by calcium. Arch. Dermatol. Res. 298 (2006) 283-290
22. Seelaar H., Schelhaas H.J., Azmani A., Küsters B., Rosso S., Majoor-Krakauer D., de Rijik M.C., Rizzu P., ten Brummelhuis M., van Doorn P.A., Kamphorst W., Willemsen R., and van Swieten J.C. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain 130 Pt 5 (2007) 1375-1385
23. Seppänen A., Autio-Harmainen H., Alafuzoff I., Särkioja T., Veijola J., Hurskainen T., Bruckner-Tuderman L., Tasanen K., and Majamaa K. Collagen XVII is expressed in human CNS neurons. Mat. Biol. 25 (2006) 185-188
24. Seppänen A., Suuronen T., Hofmann S.C., Majamaa K., and Alafuzoff I. Distribution of collagen XVII in the human brain. Brain Res. 1158 (2007) 50-56
25. Xiao S., McLean J., and Robertson J. Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta 1762 (2006) 1001-1012